Trial Profile
Phase I trial for solid tumours
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 19 Nov 2018
Price :
$35
*
At a glance
- Drugs ISB 1342 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 19 Nov 2018 New trial record
- 07 Nov 2018 According to Glenmark Pharmaceuticals media release,company intends to file an Investigational New Drug (IND) application for GBR 1342 in solid tumors and initiate a clinical trial in 2019.